Entheon Biomedical Corp. (ENBI.CN)
CAD 0.17
(0.0%)
CAD 0.17
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -359.92 Thousand | -1.95 Million | -5.61 Million | -2.83 Million | -102.31 Thousand | -221.31 Thousand |
| Net Income | -300 Thousand | -2.06 Million | -8.88 Million | -4.38 Million | -146.78 Thousand | -157.53 Thousand |
| Depreciation & Amortization | - | 2095.00 | 487.64 Thousand | 2724.00 | - | - |
| Deferred income taxes | - | - | - | - | - | -72.55 Thousand |
| Stock-based compensation | 1180.00 | 85.3 Thousand | 2.55 Million | - | 36.46 Thousand | 51.68 Thousand |
| Change in working capital | 12.61 Thousand | 436.86 Thousand | 437.45 Thousand | -1.19 Million | 7988.00 | -71.75 Thousand |
| Other non-cash items | -73.72 Thousand | -417.39 Thousand | -206.23 Thousand | 2.73 Million | 10.00 | 28.84 Thousand |
| Investing Cash Flow | 24.39 Thousand | 585.64 Thousand | -98.86 Thousand | 1.08 Million | -85 Thousand | -411.3 Thousand |
| Investments in PPE | - | - | -97.97 Thousand | -9033.00 | -85 Thousand | -411.3 Thousand |
| Acquisitions | - | - | 383.74 Thousand | 1.15 Million | - | - |
| Investment purchases | - | -25 Thousand | -405.76 Thousand | -248 Thousand | - | - |
| Sales/Maturities of investments | 24.39 Thousand | 633.87 Thousand | 21.11 Thousand | 185.08 Thousand | - | - |
| Other Investing Activities | 24.39 Thousand | -23.23 Thousand | 285.77 Thousand | -62.91 Thousand | - | - |
| Financing Cash Flow | - | - | 4.97 Million | 4.42 Million | 95.32 Thousand | 1.51 Million |
| Debt repayment | - | - | - | -3029.00 | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 3.08 Million | 4.43 Million | - | 1.67 Million |
| Other Financing Activities | - | - | 1.89 Million | 4.42 Million | 95.32 Thousand | -160.03 Thousand |
| Accounts receivables | 35.88 Thousand | -7224.00 | 80.34 Thousand | -66.11 Thousand | -6958.00 | -10.57 Thousand |
| Accounts payables | -69.32 Thousand | -633.81 Thousand | 11.83 Thousand | - | - | - |
| Inventory | - | - | 881.00 | - | - | - |
| Other working capital | -23.27 Thousand | 1.07 Million | 344.39 Thousand | -1.13 Million | 14.94 Thousand | -71.75 Thousand |
| Cash at beginning of period | 680.16 Thousand | 2.04 Million | 2.78 Million | 112.65 Thousand | 1.22 Million | 344.02 Thousand |
| Cash at end of period | 344.63 Thousand | 680.16 Thousand | 2.04 Million | 2.78 Million | 1.13 Million | 1.22 Million |
| Capital Expenditure | - | - | -97.97 Thousand | -9033.00 | -85 Thousand | -411.3 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -335.53 Thousand | -1.36 Million | -737.87 Thousand | 2.67 Million | -91.99 Thousand | 880.45 Thousand |
| Free Cash Flow | -359.92 Thousand | -1.95 Million | -5.71 Million | -2.84 Million | -187.31 Thousand | -632.61 Thousand |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -64.7 Thousand | -94.56 Thousand | -74.85 Thousand | -73.56 Thousand | -300 Thousand | -129.84 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | 21.00 | 1180.00 | -1179.00 |
| Change in working capital | -5835.00 | 5738.00 | -19.85 Thousand | 32.36 Thousand | -56.71 Thousand | -25.12 Thousand |
| Other non-cash items | - | -9459.00 | 34.53 Thousand | -54.69 Thousand | 30.22 Thousand | 44.39 Thousand |
| Investing Cash Flow | - | - | - | 9396.00 | 24.39 Thousand | 15 Thousand |
| Investments in PPE | - | 4.00 | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | 9396.00 | 24.39 Thousand | 15 Thousand |
| Other Investing Activities | - | - | - | 9396.00 | 24.39 Thousand | 15 Thousand |
| Financing Cash Flow | - | 147.5 Thousand | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 147.5 Thousand | - | - | - | - |
| Other Financing Activities | - | 147.5 Thousand | - | - | - | - |
| Accounts receivables | -38.00 | 2426.00 | -217.00 | 4561.00 | 35.88 Thousand | -3794.00 |
| Accounts payables | - | -9460.00 | -34.31 Thousand | 44.75 Thousand | -69.32 Thousand | -48.46 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -5797.00 | 3312.00 | 14.67 Thousand | -16.94 Thousand | -23.27 Thousand | 27.13 Thousand |
| Cash at beginning of period | 299.13 Thousand | 249.92 Thousand | 344.63 Thousand | 381.8 Thousand | 680.16 Thousand | 478.56 Thousand |
| Cash at end of period | 228.59 Thousand | 299.13 Thousand | 249.92 Thousand | 344.63 Thousand | 344.63 Thousand | 381.8 Thousand |
| Capital Expenditure | - | 4.00 | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -70.53 Thousand | 49.21 Thousand | -94.71 Thousand | -37.17 Thousand | -335.53 Thousand | -96.75 Thousand |
| Free Cash Flow | -70.53 Thousand | -98.28 Thousand | -94.71 Thousand | -46.57 Thousand | -359.92 Thousand | -111.75 Thousand |
NCRE
RAYALEMA
0860
UTTAMSUGAR
ESLAW
QSI